Clinical Study
Risk Stratification by Cardiac Biomarkers following Emergency Gastrointestinal Surgery
Table 1
Demographic and clinical characteristics, according to survival.
| Characteristics | 90-day survival | Alive | Dead | () | () |
| Age (Mean (Ā±SD)) | 68.8 (16.7) | 71.2 (13.9) | Gender, Male ((%)) | 24 (61.5) | 5 (55.6) | Comorbidities ((%)) | | | āIschaemic heart disease | 9 (23.7) | 1 (11.1) | āCongestive cardiac failure | 3 (7.9) | 0 (0) | āCerebrovascular disease | 2 (5.3) | 0 (0) | āType II diabetes mellitus | 7 (18.4) | 0 (0) | āRenal impairment | 7 (18.4) | 2 (22.2) | āHypertension | 13 (34.2) | 5 (55.5) | āHyperlipidaemia | 7 (18.4) | 1 (11.1) | āSmoker | 7 (18.4) | 0 (0) | Drug history ((%)) | | | āAspirin | 3 (7.9) | 0 (0) | āStatin | 9 (23.7) | 1 (11.1) | āBeta blocker | 4 (10.5) | 3 (33.3) | āACEI | 9 (23.7) | 2 (22.2) | āDiuretic | 6 (15.8) | 2 (22.2) | āCalcium channel blocker | 6 (15.8) | 3 (33.3) | Risk scores (median (mināmax)) | | | āASA score | 3 (1ā5) | 4 (3ā4.5) | āLee cardiac risk score | 2 (1ā4) | 2 (2ā4) |
|
|